Product
Novavax COVID-19 vaccine
1 clinical trial
4 indications
Indication
COVID-19Indication
Vaccine-Preventable DiseasesIndication
Upper Respiratory Tract InfectionIndication
Upper Respiratory InfectionClinical trial
Booster Epidemiological Evaluation of Health, Illness and Vaccine Efficacy Study: Randomized Trial to Compare the Clinical Efficacy of Novavax vs. mRNA COVID-19 2023-2024 Updated Vaccines Among Adults 18-49 and 50+ Years in the United StatesStatus: Recruiting, Estimated PCD: 2024-07-30